Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer. [electronic resource]
Producer: 20061109Description: 1183-9 p. digitalISSN:- 0903-1936
- Aged
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Small Cell -- drug therapy
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Resistance, Neoplasm
- Female
- Follow-Up Studies
- Humans
- Leukocyte Count
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm Staging
- Neutropenia -- chemically induced
- Neutrophils -- drug effects
- Organoplatinum Compounds -- therapeutic use
- Platelet Count
- Retreatment
- Survival Rate
- Topotecan -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.